Insider Trading History of Afeyan Noubar

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Afeyan Noubar since year 2005. The trader's CIK number is 1222012. At the time of the last reporting, Afeyan Noubar was the Director of Seres Therapeutics, Inc. . (stock ticker symbol MCRB). See this page for all insider trading activities at Seres Therapeutics, Inc. .

Note that in the past AFEYAN NOUBAR also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Afeyan Noubar since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-18 MCRB Seres Therapeutics, Inc. Buy 8,888,888 2.25 19,999,998
2019-03-04 KLDO Kaleido Biosciences, Inc. Buy 933,333 15.00 13,999,995
2015-12-09 BGMD Bg Medicine, Inc. Sale 46,438 .56 26,005
2013-11-14 RCPT Receptos, Inc. Sale 155,583 25.03 3,894,242
2013-11-15 RCPT Receptos, Inc. Sale 54,904 24.65 1,353,383
2013-11-18 RCPT Receptos, Inc. Sale 20,300 24.09 489,027
2013-09-25 BIND Bind Therapeutics, Inc Buy 20,000 15.00 300,000
2013-05-14 RCPT Receptos, Inc. Buy 107,142 14.00 1,499,988
2009-09-18 HLCS Helicos Biosciences Corp Buy 242,931 .00 0
2006-12-14 AGEN Agenus Inc Sale 5,000 1.95 9,755

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Afeyan Noubar (Director of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month